Bionovate Technologies Corp. announced earnings results for the full year ended June 30, 2019. For the full year, the company announced operating loss was USD 56,543 compared to USD 118,877 a year ago. Net loss was USD 208,896 compared to USD 1.740 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.27 a year ago.